(Reuters) -Hedge fund Starboard Value has taken a stake in Kenvue, the consumer products company that makes Band-Aid, ...

Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...

Starboard Value contends that Kenvue, with strong consumer health brands like Tylenol and Listerine, is underperforming its ...

Activist hedge fund Starboard Value believes the root cause of Pfizer’s issues are the low expected returns on its research and development investments, including investments done both internally and ...

U.S. stocks are pulling back from their all-time highs as some of the steam comes out of Wall Street’s long, record-breaking ...

The S&P 500 fell 0.2% on Monday. The Dow tumbled 0.8%, ending a three-day winning streak for the blue-chip index. After ...

JPMorgan analyst Andrea Teixeira keeps an Overweight rating on Kenvue (KVUE) after the Wall Street Journal reported Starboard Value has taken a ...

Boeing and the leaders of its machinists union reach a new tentative agreement that could end a strike that has lasted longer ...

The stock market is trading lower midday Monday, down from last week's new high. The S&P 500 slipped 0.36%, while the ...

Kenvue Inc. (NYSE:KVUE) shares are moving higher Monday following a report suggesting activist investor Starboard Value has ...

The Wall Street Journal reported late Sunday that Starboard Value sees Kenvue as having some of the top consumer brands in its sector, including Tylenol and Listerine, but wants t ...

Activist investor Starboard Value, which picked up a $1 billion stake in Pfizer earlier this month, now reportedly has ...